Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of Thromboembolic Events”

319 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 319 results

Not applicableLooking for participantsNCT05476913
What this trial is testing

GEKO Venous Thromboembolism Prevention Study

Who this might be right for
Stroke, AcuteVenous ThromboembolismDeep Vein Thrombosis+1 more
Firstkind Ltd 1,200
Testing effectiveness (Phase 2)Study completedNCT00244725
What this trial is testing

Odiparcil For The Prevention Of Venous Thromboembolism

Who this might be right for
Deep Vein ThrombosisFibrillation, AtrialVenous Thromboembolism+1 more
GlaxoSmithKline 961
Post-approval studies (Phase 4)Study completedNCT02412982
What this trial is testing

Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients

Who this might be right for
Traumatic InjuryVenous Thromboembolism
University of Cincinnati 103
Testing effectiveness (Phase 2)Study completedNCT05618808
What this trial is testing

A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants

Who this might be right for
Venous Thromboembolism
Regeneron Pharmaceuticals 373
Not applicableUnknownNCT05382481
What this trial is testing

Anti Xa Monitoring Low Molecular Weight Heparin on Prevention of Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Xuanwu Hospital, Beijing 858
Testing effectiveness (Phase 2)Study completedNCT01629381
What this trial is testing

Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy

Who this might be right for
Venous ThromboembolismHaemorrhage
University of Padova 500
Not applicableLooking for participantsNCT06947707
What this trial is testing

Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

Who this might be right for
Cerebral Venous ThrombosisAnticoagulants and Thrombotic DisordersAnticoagulation Treatment+6 more
Xuanwu Hospital, Beijing 1,486
Not applicableStudy completedNCT06009484
What this trial is testing

VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program

Who this might be right for
Deep Vein Thrombosis, Pulmonary EmbolusColon Cancer
Nordsjaellands Hospital 2,141
Not applicableEnded earlyNCT01153698
What this trial is testing

Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery

Who this might be right for
Venous ThromboembolismArthroplasty, Replacement
Boehringer Ingelheim 167
Large-scale testing (Phase 3)Study completedNCT01234064
What this trial is testing

Graduated Compression Stockings (GCS) Pilot Substudy

Who this might be right for
Venous Thromboembolism
Hamilton Health Sciences Corporation 50
Not applicableUnknownNCT03405571
What this trial is testing

Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias.

Who this might be right for
Multiple MyelomaVenous Thromboembolism
University of Athens 800
Testing effectiveness (Phase 2)Study completedNCT00375609
What this trial is testing

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)

Who this might be right for
Thromboembolism
Portola Pharmaceuticals 215
Not applicableStudy completedNCT00604370
What this trial is testing

Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge

Who this might be right for
Venous Thromboembolism
Brigham and Women's Hospital 2,500
Large-scale testing (Phase 3)Study completedNCT00135876
What this trial is testing

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Who this might be right for
Venous ThromboembolismBrain Tumors
Ontario Clinical Oncology Group (OCOG) 512
Post-approval studies (Phase 4)Ended earlyNCT04710732
What this trial is testing

Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.

Who this might be right for
Venous Thromboembolism
Pirogov Russian National Research Medical University 9
Large-scale testing (Phase 3)Study completedNCT01205932
What this trial is testing

Dose-confirmatory Bridging Study in Total Hip Replacement

Who this might be right for
Venous Thromboembolism
Bayer 402
Not applicableActive Not RecruitingNCT02321137
What this trial is testing

Left Atrial Appendage CLOSURE for the Prevention of Thromboembolisms in Patients Undergoing Aortic Bioprosthesis Surgery

Who this might be right for
Aortic Stenosis
University of Turku 1,040
Not applicableStudy completedNCT00846807
What this trial is testing

Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery

Who this might be right for
Arthroplasty, ReplacementThromboembolism
Boehringer Ingelheim 5,476
Not applicableStudy completedNCT05471830
What this trial is testing

An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting

Who this might be right for
Prevention of Thromboembolic EventsAtrial Fibrillation
Bayer 600
Post-approval studies (Phase 4)Looking for participantsNCT06845423
What this trial is testing

Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk

Who this might be right for
Venous Thromboembolism (VTE)Post Partum Women
University Hospital, Brest 2,400
Load More Results